Stryker (NYSE:SYK) misses Q3 2026 sales expectations, stock drops
Medical technology company Stryker (NYSE:SYK) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 7.6% year on year to $6.52 billion. Its non-GAAP profit of $3.52 per share was 0.8% below analysts’ consensus estimates.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo